These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15760060)
1. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. Pisal S; Shelke V; Mahadik K; Kadam S AAPS PharmSciTech; 2004 Sep; 5(4):e63. PubMed ID: 15760060 [TBL] [Abstract][Full Text] [Related]
2. Water-in-sorbitan monostearate organogels (water-in-oil gels). Murdan S; van den Bergh B; Gregoriadis G; Florence AT J Pharm Sci; 1999 Jun; 88(6):615-9. PubMed ID: 10350497 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of sorbitan monostearate and sesame oil-based organogels for topical delivery of antimicrobials. Singh VK; Pramanik K; Ray SS; Pal K AAPS PharmSciTech; 2015 Apr; 16(2):293-305. PubMed ID: 25277240 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents. Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979 [TBL] [Abstract][Full Text] [Related]
5. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation. Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977 [TBL] [Abstract][Full Text] [Related]
6. Organogel-based system for transdermal delivery of propranolol. Bhatnagar S; Vyas SP J Microencapsul; 1994; 11(4):431-8. PubMed ID: 7931942 [TBL] [Abstract][Full Text] [Related]
7. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Zaki NM; Awad GA; Mortada ND; Abd Elhady SS Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822 [TBL] [Abstract][Full Text] [Related]
8. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery. Patil SB; Sawant KK J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060 [TBL] [Abstract][Full Text] [Related]
9. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane. Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193 [TBL] [Abstract][Full Text] [Related]
10. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. Patil P; Joshi P; Paradkar A AAPS PharmSciTech; 2004 Jul; 5(3):e42. PubMed ID: 15760075 [TBL] [Abstract][Full Text] [Related]
12. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339 [TBL] [Abstract][Full Text] [Related]
13. Interaction of a nonionic surfactant-based organogel with aqueous media. Murdan S; Gregoriadis G; Florence AT Int J Pharm; 1999 Apr; 180(2):211-4. PubMed ID: 10370191 [TBL] [Abstract][Full Text] [Related]
14. Sorbitan ester organogels for transdermal delivery of sumatriptan. Upadhyay KK; Tiwari C; Khopade AJ; Bohidar HB; Jain SK Drug Dev Ind Pharm; 2007 Jun; 33(6):617-25. PubMed ID: 17613026 [TBL] [Abstract][Full Text] [Related]
15. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery. Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761 [TBL] [Abstract][Full Text] [Related]
16. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation. Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409 [TBL] [Abstract][Full Text] [Related]
17. Thermally reversible xyloglucan gels as vehicles for nasal drug delivery. Mahajan HS; Tyagi V; Lohiya G; Nerkar P Drug Deliv; 2012; 19(5):270-6. PubMed ID: 22823894 [TBL] [Abstract][Full Text] [Related]
18. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation. Wang D; Zhao J; Liu X; Sun F; Zhou Y; Teng L; Li Y Eur J Pharm Sci; 2014 Aug; 60():40-8. PubMed ID: 24815944 [TBL] [Abstract][Full Text] [Related]
19. Pluronic lecithin organogel as a topical drug delivery system. Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074 [TBL] [Abstract][Full Text] [Related]
20. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. Patel VM; Prajapati BG; Patel MM AAPS PharmSciTech; 2007 Jun; 8(2):Article 45. PubMed ID: 17622120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]